Effects of polymorphism of HLA on binding of antigenic peptides to HLA and recognition of peptides complexed with HLA by T cell receptor
Effects of polymorphism of HLA on binding of antigenic peptides to HLA and recognition of peptides complexed with HLA by T cell receptor
批准号:
03452276
负责人:
NISHIMURA Yasuharu
金额:
$4.35万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1993
中文摘要
点击翻译按钮获取中文摘要
英文摘要
HLA-DR molecules are highly polymorphic molecules and bind antigenic peptides to present it to CD4 positive helper T cells. The particular DR alleles are thought to determine susceptibility to autoimmune diseases because the frequencies of particular DR allelse are increased in the patients group as compared with those in healthy controls. Thus DRB1 ^<**>0405 and DRB1 ^<**>0406 which differs in only four amino acid residues from DRB1 ^<**>0405 control susceptibility to rheumatoid arthritis and insulin autoimmune syndrome respectively. We have investigated the structural characteristics of antigenic peptides bound to either DRB1 ^<**>0405 or DRB1 ^<**>0406 molecules. For this aim, self peptides bound to purified DRB1 ^<**>0405 molecules were isolated and fractionated by a reversed phase HPLC.Amino acid sequences of seven independent peptides were determined and four of them were identified to be fragments of known proteins. These self peptides were synthesized and radio-iodinated, and binding of labeled peptides to DR molecules were investigated. The strongest binder among seven self peptides was identified and this peptide bound to both DRB1 ^<**>0405 and DRB1 ^<**>0406 equally. The binding inhibition assay, in which binding activity of a peptide to be tested was determined by measuring inhibitory effect of the excess amount of peptide on binding of the labeled strongest binder to DR molecule, was established. In order to determine amino acid residues important for DR binding in the strongest binder, analogue peptides having only one amino acid substitution from the original peptides were synthesized and their binding to both DRB1 ^<**>0405 and DRB1 ^<**>0406 was investigated. DR binding peptides consisted of nine to twenty amino acids were bound at three major anchorage amino acid residues of the peptide to DR molecule. These three anchorage residues were separated by two and one intervening amino acids. The first
期刊论文(226)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Inamitsu,T.: "Different recognition of transgenic HLA-DQw6 molecules by mouse CD4^+ and CD8^+ T cells." Immunogenetics. 35. 46-50 (1992)
Inamitsu,T.:“小鼠 CD4^ 和 CD8^ T 细胞对转基因 HLA-DQw6 分子的不同识别。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
西村 泰治: "第463回新潟医学会シンポジウム「HLAによるヒト免疫応答の個体差の決定」" 新潟医学会雑誌. 105. 438-444 (1991)
Taiji Nishimura:“第 463 届新泻医学会研讨会“通过 HLA 确定人类免疫反应的个体差异”新泻医学会杂志 105. 438-444 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
西村 泰治: "Topics;日米シンポジウム" 免疫Immunology Frontier. 第3巻3号. 205-211 (1993)
Taiji Nishimura:“主题;日美研讨会”免疫学前沿,第 3 卷,第 3 期。205-211 (1993)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
西村 泰治: "膠原病の免疫遺伝学" 内科. 第73巻4号(印刷中). (1994)
Taiji Nishimura:“胶原病的免疫遗传学”,第 73 卷,第 4 期(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
西村 泰治: "生化学実験講座第12巻「分子免疫学II免疫遺伝学・アレルギー」「トランスジェニックマウスを用いたMHCの解析」" 東京化学同人社,日本生化学会編, 8 (1991)
西村太二:《生物化学实验教程第12卷“分子免疫学II免疫遗传学/过敏”“使用转基因小鼠的MHC分析”,东京化学同人社编辑,日本生物化学会,8(1991)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 132 条
Development of new cancer immunotherapy aiming activation of both anti-tumor killer and helper T cells
-
批准号:24300334
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2012
-
负责人:NISHIMURA Yasuharu
-
依托单位:
Development of cellular cancer immunotherapy by using humaniPS-cell-derived dendritic cells and ideal cancer-associated antigens
-
批准号:23650609
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:NISHIMURA Yasuharu
-
依托单位:
Investigation on the molecular mechanisms of antigen presentation and recognition.
-
批准号:14370115
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.9万
-
财政年份:2002
-
负责人:NISHIMURA Yasuharu
-
依托单位:
Identification of tumor-specific antigens recognized by human T cells
-
批准号:12213111
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$33.41万
-
财政年份:2000
-
负责人:NISHIMURA Yasuharu
-
依托单位:
THE DIVESITY IN ANTIGEN RECOGNITION AND RESPONSE OF ANTIGEN-SPECIFIC HUMAN CD4^+ T-CELL CLONES
-
批准号:11557027
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:1999
-
负责人:NISHIMURA Yasuharu
-
依托单位:
Analysis of TCR/HLA/ peptide interaction and investigation of etiology of autoimmune diseases
-
批准号:11694294
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$6.25万
-
财政年份:1999
-
负责人:NISHIMURA Yasuharu
-
依托单位:
ANALYSIS OF AUTOANTIGENIC PEPTIDE-HLA CLASS II COMPLEXES ASSOCIATED WITH AUTOIMMUNE DISEASES
-
批准号:09470097
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.17万
-
财政年份:1997
-
负责人:NISHIMURA Yasuharu
-
依托单位:
An approach to generate a library of CHO cells expressing diverse HLA class II plus peptide complexes for identification of TCR-ligands by using CLIP-substituted invariant chains
-
批准号:08557027
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$8.32万
-
财政年份:1996
-
负责人:NISHIMURA Yasuharu
-
依托单位:
IDENTIFICATION AND PREDICTION OF T-CELL EPITOPES BY USING HLA CLASS II-BINDING PEPTIDE MOTIFS
-
批准号:06454222
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1994
-
负责人:NISHIMURA Yasuharu
-
依托单位:
Production of monoclonal antibody specific to HLA by utilizing HLA transgenic mice.
-
批准号:01870026
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$2.62万
-
财政年份:1989
-
负责人:NISHIMURA Yasuharu
-
依托单位:
Analysis of the Biological Function of CD5 Molecule.
-
批准号:63480170
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1988
-
负责人:NISHIMURA Yasuharu
-
依托单位:
海外基金